BXSYNTH Beximco Synthetics Limited
Pharmaceuticals & Chemicals
Tk 8.4 as of 2025-04-30 15:01:34
Rank 314 of all scored
Data completeness 40%
Data completeness 40%
Override: Avoid. Negative EPS.
Limited data for this company (40% of inputs available): treat the score with caution.
Score breakdown
Consistency —
Profitability —
Solvency 39
Valuation 24
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Concerns
- Solvency High debt: debt/equity 1.54x (above 1.5)
- Valuation No P/E: the company is loss-making
Risk flags
- Category Z (poor/defaulting: gambling favourite, avoid for long-term)
- Small cap (< Tk 200 cr): most exposed to manipulation and volatility
- Within 3.7% of its 52-week low: check WHY before treating it as cheap
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
3.7% above the low, 3.5% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 35.7%
- Institution 24.6%
- Foreign 0%
- Public 39.7%
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 65.8%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.